2016
DOI: 10.1016/j.jhin.2015.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Evolving epidemiology of carbapenemase-producing Enterobacteriaceae in Portugal: 2012 retrospective cohort at a tertiary hospital in Lisbon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…The most common carbapenemase described worldwide is KPC-2 [18,19,20,21,22] but KPC-3 has already been identified in the United States [23], Israel [22], Italy [24] and Spain [25]. In Portugal, the first carbapenem-resistant K. pneumoniae was identified in 2009 [26] and since then, dissemination to other Enterobacteriaceae [27] and the increasing frequency of hospital outbreaks [28] has led to the creation of the Epidemiological Surveillance of Antimicrobial Resistance Guidelines, which contains mandatory notification of these pathogens [29].…”
Section: Discussionmentioning
confidence: 99%
“…The most common carbapenemase described worldwide is KPC-2 [18,19,20,21,22] but KPC-3 has already been identified in the United States [23], Israel [22], Italy [24] and Spain [25]. In Portugal, the first carbapenem-resistant K. pneumoniae was identified in 2009 [26] and since then, dissemination to other Enterobacteriaceae [27] and the increasing frequency of hospital outbreaks [28] has led to the creation of the Epidemiological Surveillance of Antimicrobial Resistance Guidelines, which contains mandatory notification of these pathogens [29].…”
Section: Discussionmentioning
confidence: 99%
“…During the same period the share of isolates with combined resistance to third generation cephalosporins, fluoroquinolones and aminoglycosides (26.5% in 2019) oscillated without an upward trend 6 . Several recent small epidemiological studies in Portugal have focused on carbapenemase producing Kp isolates 11 16 , and bla KPC-3 was the most frequently identified carbapenem resistance gene. The bla KPC-3 gene is most frequently located within the Tn 4401 d transposon, and IncN, IncFII, IncFIB and IncFIIA plasmid families are the main traffickers 11 , 13 , 15 , 17 .…”
Section: Introductionmentioning
confidence: 99%
“…That report also showed that Portugal faced an annual increasing trend of carbapenem resistance among K. pneumoniae since 2014 (1.8% in 2014, 3.4% in 2015, 5.2% in 2016, and 8.6% in 2017), exceeding the overall prevalence for Europe (7.2%). Nevertheless, data on the molecular epidemiology of nosocomial carbapenemase-producing K. pneumoniae in Portugal are still limited, and the existing studies include isolates recovered until 2014 only ( 10 , 12 , 13 ). Therefore, the aim of our study was to provide updated epidemiologic data on contemporary carbapenemase-producing K. pneumoniae in an acute-care facility hospital in Portugal by characterizing a collection of nonrepetitive isolates recovered during a 6-year period (2013–2018).…”
mentioning
confidence: 99%